Most important corporate projects

"Europe's Research Infrastructure for Brain Research"

The EBRAINS project is the new digital research infrastructure created by the European initiative, the Human Brain Project, aimed at fostering research related to the brain and neurological diseases, benefiting both patients and society at large.

The objective of the EBRAINS project, funded by European Union funds, is to provide researchers in the field of neuroscience with a broad range of tools to improve the understanding of neurological diseases, which are becoming increasingly prevalent worldwide and pose significant morbidity and mortality. Research and innovation in this area are crucial, as they enable improvements in the diagnosis and treatment of these pathologies.

"Strategies and Technologies for United and Resilient Critical Infrastructures and Vital Services in Pandemic-Stricken Europe"

The SUNRISE project is funded by the European Commission with €9.5 million and has an expected duration of 3 years, starting in October 2022. It involves 41 entities from 9 countries (Italy, Slovenia, France, Estonia, the Czech Republic, Serbia, Israel, and Spain), including operators of critical infrastructures (healthcare, telecommunications, food, water, energy, and transportation), public administrations, experts in social sciences and humanities, epidemiology and climate experts, and technology entities dedicated to software development. Its objective is to identify vital services and critical infrastructures in the event of a pandemic, their dependencies, and the risks they face, in order to develop the necessary measures to minimize the adverse effects in critical situations. To achieve this, several tools will be developed and validated within this project to ensure greater availability, reliability, security, robustness, cost-effectiveness, adaptability, and continuity of specific vital services in the event of a pandemic.

Quirónsalud will be part of the Spanish cluster, together with the Quirónsalud University Hospital in Madrid, to understand the role of each critical infrastructure operator in their sector and their interdependence with other sectors, aiming to establish collaboration policies that help minimize adverse effects in the event of a health crisis.

Additionally, Quirónsalud will also participate in a working group responsible for designing and validating a tool to support the management of changes in demand and resource needs during critical situations.

"An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum"

PROCANCER-I is an international cooperative project funded by the European Commission with nearly €10 million and is set to last 4 years (starting in October 2020). The ProCancer-I project brings together 20 partners from 11 different countries, including leading centers in prostate cancer treatment, global leaders in artificial intelligence, and innovative SMEs. Its goal is to design and develop a European infrastructure that will house the largest collection of prostate cancer images obtained through magnetic resonance imaging (MRI), along with clinical information on diagnosis, treatment, and patient follow-up. This database, involving nearly 23,000 patients, will facilitate the development of artificial intelligence models based on novel ensemble learning methodologies, which can be used as diagnostic tools for tumor characterization, metastatic potential assessment, and early detection of disease recurrence.

The Quirónsalud Group participates in this project through the imaging diagnostic service of the Quirónsalud Valencia Hospital, in collaboration with the urology and pathology departments, providing a database of prostate MRI studies that includes images, imaging biomarkers, and clinical data. Quirónsalud will contribute 800 retrospective cases and 200 prospective cases and will participate in the development of the infrastructure, the design of artificial intelligence models, clinical evaluation of the tool, ethical and legal aspects, and the dissemination and exploitation of project results.

"Implementation of personalized risk prediction and prevention of sudden cardiac death after myocardial infarction"

This project is expected to last five years, starting in October 2020, and is funded by the European Commission. It involves 21 organizations from different parts of Europe. It focuses on the prevention and prediction of sudden cardiac death, which remains one of the unresolved public health issues, currently causing around 20% of deaths in Europe, with an estimated annual incidence of between 350,000 and 700,000 cases. The project aims to demonstrate that, compared to standard practice, the implementation and use of personalized risk information in patients who have suffered a myocardial infarction can help predict and prevent sudden cardiac death, substantially improving the health benefits for these patients and optimizing healthcare resources.

The project is led by the Leipzig Heart Institute (Helios), part of the Fresenius Group, and Quirónsalud will participate in the clinical research carried out across Europe, involving more than 3,500 patients.

"Smart Big Data Platform to Offer Evidence-based Personalised Support for Healthy and Independent Living at Home"

The SMARTBEAR project is a competitive initiative funded by the European Commission in the field of "Trusted digital solutions and cybersecurity in health and care."

The objective is to create a platform that will integrate heterogeneous information from sensors, medical records, and mobile products that will track the daily life data of individuals over 65 years old. This data will be analyzed to provide the evidence necessary to deploy an automated decision-making tool that offers personalized interventions aimed at promoting a healthy and independent life.